Trademark Overview
On Friday, September 13, 2024, a trademark application was filed for QPARIK with the United States Patent and Trademark Office. The USPTO has given the QPARIK trademark a serial number of 98750230. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, September 13, 2024. This trademark is owned by Incyte Holdings Corporation. The QPARIK trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of dermatological disorders; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders